We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Ym3.5
Yerba Mate Research
Mostly mechanism / observational
23 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Yerba Mate studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2010–2026 with a typical study size of 4,629 participants.
Based on 23 studies · 5 meta-analyses · 13 RCTs · 4,642 total participants
Confidence
High confidence
By outcome
Weight managementSmall reductions in body-fat mass and waist-hip ratio in one 12-week RCT; meta-analysis found weight/BMI effects 'limited' · 8-12 weeks
Mostly mechanism / observational4 studies
Safety profile
Too few graded studies1 study
Active research area
10 studies in the last 5 years · Latest meta-analysis: 2025
In plain English: In conclusion, YM represents a promising source of functional ingredients with broad potential for health-oriented and culinary applications.
Zhang C, Chen J, Ruan S, Wang Z, Dai X. · Critical reviews in food science and nutrition (2026)
Evidence supports several health benefits of YM, including anti-inflammatory, antioxidant, anti-obesity, and cardioprotective properties, along with potential prebiotic effects.
However, safety concerns exist, particularly the possible formation of polycyclic aromatic hydrocarbons (PAHs) during traditional drying processes.
Beyond its use as a beverage, YM shows strong potential in the food industry for applications in functional foods, nutraceuticals, and natural preservatives.
In plain English: Future research should include rigorously designed randomized trials and mechanistic studies using advanced human-relevant platforms, such as organoids and organ-on-chip systems.
Cassotta M, Cao Q, Hu H, Martinez CR, Dzul Lopez LA, Gracia Villar S, Battino M, Giampieri F. · Nutrients (2025)
Preclinical studies appear to indicate modulation of inflammatory and redox pathways relevant to RA.
Conclusions: Yerba mate and its constituents show preliminary indications of anti-inflammatory and antioxidant effects with potential relevance to RA pathophysiology.
However, in the absence of clinical trials in RA patients, conclusions remain tentative, constrained by small sample sizes, methodological heterogeneity, species differences, and internal validity concerns.
In plain English: ORs for ESCC increased linearly with cumulative maté consumption and were unrelated to intensity... The strength of association increased with higher maté temperatures.
Lubin JH et al. · Cancer Epidemiol Biomarkers Prev (2014)
Pooled case-control data: 1,400 cases and 3,229 controls
Ever-use OR 1.60 (95% CI 1.2-2.2); risk rose linearly with cumulative consumption
Strength of association increased with higher mate temperature (a key, modifiable safety factor)
In plain English: Yerba Maté consumption may demonstrate favorable effects on glycemic control, though its impact on lipid profiles and weight management appears to be limited.
Li D et al. · Front Endocrinol (Lausanne) (2025)
Pooled 13 RCTs; in pre-diabetic subjects found lower postprandial glucose (MD -12.76), HbA1c (MD -0.37), and HOMA index (MD -0.24)
NO significant effect on triglycerides, total/HDL/LDL cholesterol, fasting glucose, fasting insulin, waist circumference, or BMI
Reported adverse events included insomnia, tachycardia, angina, headache, GI discomfort, and mucosal irritation